Home>>Lipids>> Prostaglandins>>15-keto Fluprostenol isopropyl ester

15-keto Fluprostenol isopropyl ester (Synonyms: 15keto Travoprost)

Catalog No.GC41933

15-keto Fluprostenol isopropyl ester (15-Keto Fluprostenol isopropyl ester) is a metabolite of Travoprost.

Products are for research use only. Not for human use. We do not sell to patients.

15-keto Fluprostenol isopropyl ester Chemical Structure

Cas No.: 404830-45-1

Size Price Stock Qty
1mg
$78.00
In stock
5mg
$352.00
In stock
10mg
$575.00
In stock
25mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Travoprost is an F-series prostaglandin analog which has been approved for use as an ocular hypotensive drug. Oxidation of the C-15 hydroxyl group without isopropyl ester hydrolysis produces 15-keto fluprostenol isopropyl ester (15-keto travoprost). 15-keto Travoprost is a potential metabolite of travoprost when administered to intact animals. 15-keto Travoprost is also one of the common minor impurities found in commercial preparations of the bulk drug compound. In general, F-series prostaglandin analogs with a 15-keto functional group lose a great deal of their FP receptor binding affinity, but retain enough to show a continued weak IOP hypotensive response. The efficacy of 15-keto travoprost as an ocular hypotensive has not been established.

Reviews

Review for 15-keto Fluprostenol isopropyl ester

Average Rating: 5 ★★★★★ (Based on Reviews and 12 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 15-keto Fluprostenol isopropyl ester

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.